Surfactant-derived proteins as markers of alveolar membrane damage in heart failure

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Gargiulo, Paola ^a   Banfi, Cristina ^b   Ghilardi, Stefania ^b   Magrì, Damiano ^c   Giovannardi, Marta ^b   Bonomi, Alice ^b   Salvioni, Elisabetta ^b   Battaia, Elisa ^d   Filardi, Pasquale Perrone ^e   Tremoli, Elena ^b,f   Agostoni, Piergiuseppe ^b,f  

^a SDN IRCCS Institute of Diagnostic and Nuclear Research   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN D; AGER PROTEIN, HUMAN; BIOLOGICAL MARKER; CARBON MONOXIDE;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD SAMPLING; BODY MASS; CAPILLARY WALL; CARDIOMYOPATHY; CARDIOPULMONARY EXERCISE TEST; CHEMOLUMINESCENCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; HEART FAILURE; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOBLOTTING; LIMIT OF DETECTION; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; QUANTITATIVE ANALYSIS; BLOOD; EXERCISE TEST; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; MUCOSA; PATHOLOGY; VASCULARIZATION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGED; BIOMARKERS; CARBON MONOXIDE; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY FUNCTION TESTS;

EID: 84919360899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115030     Document Type: Article

References (41)

1. Agostoni P, Bussotti M, Cattadori G, Margutti E, Contini M, et al. (2006) Gas diffusion and alveolar-capillary unit in chronic heart failure. European heart journal 27: 2538-2543.
2. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of clinical investigation 108: 949-955.
3. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respiratory physiology & neurobiology 162: 210-215.
4. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, et al. (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63: 1083-1089.
5. Goerke J (1998) Pulmonary surfactant: functions and molecular composition. Biochimica et biophysica acta 1408: 79-89.
6. Serrano AG, Perez-Gil J (2006) Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chemistry and physics of lipids 141: 105-118.
7. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, et al. (2006) Surfactant proteins SP-A and SP-D: Structure, function and receptors. Molecular Immunology 43: 1293-1315.
8. Sorensen GL, Husby S, Holmskov U (2007) Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212: 381-416.
9. De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Chew DP, et al. (2004) Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation 110: 1091-1096.
10. Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, et al. (2002) Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA: the journal of the American Medical Association 287: 2228-2235.
11. Hill J, Heslop C, Man SF, Frohlich J, Connett JE, et al. (2011) Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. European heart journal 32: 1918-1925.
12. Xie F, Wang X, Ding Z, Fan P, Fan L, et al. (2013) Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease. J Cardiovasc Med (Hagerstown) 14: 461-465.
13. Kobayashi H, Kanoh S, Motoyoshi K (2008) Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 13: 385-392.
14. Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, et al. (2011) Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respiratory research 12: 29.
15. De Pasquale CG, Arnolda LF, Doyle IR, Grant RL, Aylward PE, et al. (2003) Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema. Critical care medicine 31: 1060-1067.
16. Magri D, Brioschi M, Banfi C, Schmid JP, Palermo P, et al. (2009) Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure. Circulation Heart failure 2: 175-180.
17. Agostoni P, Banfi C, Magri D, Vignati C, Doria E, et al. (2011) Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery. Respiratory physiology & neurobiology 178: 256-260.
18. Agostoni P, Banfi C, Brioschi M, Magri D, Sciomer S, et al. (2011) Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study. The European respiratory journal 37: 841-847.
19. Magri D, Mariotta S, Banfi C, Ricotta A, Onofri A, et al. (2013) Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis. Respiratory medicine 107: 1617-1624.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. The European respiratory journal Supplement 16: 5-40.
21. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, et al. (2007) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Annals of internal medicine 147: 633-638.
22. Huang YC, Helms MJ, MacIntyre NR (1994) Normal values for single exhalation diffusing capacity and pulmonary capillary blood flow in sitting, supine positions, and during mild exercise. Chest 105: 501-508.
23. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, et al. (1972) Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during submaximal exercise. Clinical science 42: 325-335.
24. Elborn JS, Stanford CF, Nicholls DP (1990) Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure. The need for a preliminary test. European heart journal 11: 75-81.
25. Agostoni P, Bianchi M, Moraschi A, Palermo P, Cattadori G, et al. (2005) Work-rate affects cardiopulmonary exercise test results in heart failure. European journal of heart failure 7: 498-504.
26. Beaver WL, Wasserman K, Whipp BJ (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol (1985) 60: 2020-2027.
27. Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analytical biochemistry 166: 368-379.
28. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72: 248-254.
29. Schmekel B, Bos JA, Khan AR, Wohlfart B, Lachmann B, et al. (1992) Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Thorax 47: 603-608.
30. Efron B (1979) Bootstrap Methods: Another Look at the Jackknife. The Annals of Statistics 7: 1-26.
31. De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Russell AE, et al. (2005) Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction. Clinical and experimental pharmacology & physiology 32: 622-627.
32. Agostoni P, Swenson ER, Fumagalli R, Salvioni E, Cattadori G, et al. (2013) Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project. Respiratory physiology & neurobiology 188: 223-228.
33. Whitsett JA, Weaver TE (2002) Hydrophobic surfactant proteins in lung function and disease. The New England journal of medicine 347: 2141-2148.
34. Bussieres LM, Pflugfelder PW, Ahmad D, Taylor AW, Kostuk WJ (1995) Evolution of resting lung function in the first year after cardiac transplantation. The European respiratory journal 8: 959-962.
35. Agostoni PG, Guazzi M, Bussotti M, Grazi M, Palermo P, et al. (2000) Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. Journal of the American College of Cardiology 36: 1600-1604.
36. Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G (2002) Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. European heart journal 23: 467-476.
37. Contini M, Apostolo A, Cattadori G, Paolillo S, Iorio A, et al. (2013) Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: The CARNEBI trial. International journal of cardiology 168: 2134-2140.
38. Paolillo S, Pellegrino R, Salvioni E, Contini M, Iorio A, et al. (2013) Role of alveolar beta2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans. PloS one 8: e61877.
39. Agostoni P, Apostolo A, Cattadori G, Salvioni E, Berna G, et al. (2010) Effects of beta-blockers on ventilation efficiency in heart failure. American heart journal 159: 1067-1073.
40. Agostoni P, Contini M, Cattadori G, Apostolo A, Sciomer S, et al. (2007) Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? European journal of heart failure 9: 827-833.
41. Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nature reviews Immunology 5: 58-68.